Antitumor agent-79 exhibits potent antiproliferative activity against hepatocellular carcinoma and breast cancer cells (IC50 = 0.7–7.9 μM); induces apoptosis in cancer cells; demonstrates in vivo antitumor efficacy; and can be used in cancer research.